Published onCHOP Talk: A Voice for Children
May 2012 — Stephan A. Grupp, MD, PhD, a pediatric oncologist and director of Translational Research at the Center for Childhood Cancer Research at CHOP, testified before the Pennsylvania Senate Majority Policy Committee on the importance of the Commonwealth Universal Research Enhancement (CURE) Program.
The CURE program provides state funding to support health research and scientific discovery and is funded by Act 77, the Tobacco settlement. CURE funding has been extremely important to Dr. Grupp’s groundbreaking research on pediatric leukemia.
Categories: Pennsylvania Policy Update